Success Story: From Regenerative Research to NIW Approval for a Resident Physician
Client’s Testimonial:
"The dream team.”
In June 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Resident Physician in the Field of Medical Sciences (Approval Notice).
General Field: Medical Sciences
Position at the Time of Case Filing: Resident Physician
Country of Origin: Taiwan
State of Residence at the Time of Filing: Minnesota
Approval Notice Date: June 2026
Processing Time: 13 months, 3 days (Premium Processing Requested)
Case Summary:
This NIW approval involved a physician-scientist whose work spanned neuroscience, regenerative medicine, and reconstructive surgery, ultimately converging on a common goal: helping patients recover more effectively from serious injuries and disease.
The client, a resident physician from Taiwan, proposed to continue developing novel regenerative therapeutics and advanced biological delivery systems to improve clinical outcomes for patients undergoing complex reconstructive and restorative procedures. Focusing on comprehensive tissue regeneration and cellular repair, his efforts aim to accelerate recovery timelines while mitigating the long-term physiological burdens often associated with invasive surgical interventions.
Underscoring the high value of this work, his research attracted significant support from a major state funding program that is dedicated to advancing medical innovations that directly improve patient care.
The petition documented an extensive record of achievement, including 52 peer-reviewed journal articles, 23 conference abstracts, and 3 book chapters. His work had accumulated more than 2,100 citations, and at least 13 publications ranked among the most-cited Clinical Medicine articles for their publication years, including one paper in the top 1%, four in the top 10%. These metrics reflected not merely publication activity, but substantial independent reliance by researchers studying regenerative medicine, reconstructive surgery, neurology, and related fields.
The case was further supported by four recommendation letters from experts familiar with the significance of the client's contributions. One recommender observed that his work had produced "significant advances that address factors behind suicide and neurological diseases and offer transformative solutions." Together, the letters highlighted the unusual combination of scientific depth and clinical relevance demonstrated throughout his career.
North America Immigration Law Group (Chen Immigration Law Associates) presented the case by connecting the client's past accomplishments to his future endeavor in regenerative medicine. After premium processing was requested in April 2026, USCIS approved the I-140 NIW petition within 45 days. The approval recognized the value of research aimed at improving tissue regeneration, enhancing reconstructive outcomes, and helping trauma patients and cancer survivors achieve better recovery and quality of life.

